Catalyst Wire Dossier Catalyst Wire Dossier

Forodesine hydrochloride

forodesine hydrochloride · BioCryst Pharmaceuticals
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Forodesine hydrochloride, covering 2012-01-19 to 2013-09-23. Get the full timeline:

Most recent: Clinical Trial Update: Oral Forodesine Hydrochloride (BCX-1777) in Patients With Recurrent or Refractory T/NK-cell Malignancies [Phase 1]

See pricing